Novo Nordisk has seen a significant decline in its stock price due to competition in the pharmaceutical market, offering a potential buying opportunity with growth prospects in the obesity drug market. Moody’s Corporation remains a stable investment with a strong reputation and steady profitability, while Mastercard continues to benefit from the global shift towards cashless payments, offering solid growth potential. Consider these top dividend stocks for investment opportunities in November.

Read more at Yahoo Finance: 3 Top Dividend Stocks to Buy in November